Clinical trial
A Study of the SMART Stent in the Treatment SFA Disease.
NCT00232869 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00232869 |
|---|---|
| Title | A Study of the SMART Stent in the Treatment SFA Disease. |
| Official title | A Clinical Investigation of the SIROlimus Coated Cordis SMART™ Nitinol Selfexpandable Stent for the Treatment of Obstructive Superficial Femoral Artery Disease. |
| Acronym | SIROCCO |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Artery Disease |
| Intervention type | Device |
| Interventions | drug-eluting stent, bare-metal stent |
| Enrollment | 93 |
| Start date | Feb 1, 2001 |
| Primary completion | Jun 1, 2003 |
| Completion | May 1, 2009 |
| First posted | Oct 5, 2005 |
| Last update posted | Feb 4, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: